Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci

Nature Genetics

Volumn 45, Issue 7, 2013, Pages 730-738

  Cortes, Adrian ^a   Hadler, Johanna ^a   Pointon, Jenny P ^b   Robinson, Philip C ^a   Karaderi, Tugce ^b   Leo, Paul ^a   Cremin, Katie ^a   Pryce, Karena ^a   Harris, Jessica ^a   Lee, Seunghun ^c   Joo, Kyung Bin ^c   Shim, Seung Cheol ^d   Weisman, Michael ^e   Ward, Michael ^f   Zhou, Xiaodong ^g   Garchon, Henri Jean ^h,i   Chiocchia, Gilles ^h   Nossent, Johannes ^j,k   Lie, Benedicte A ^l,m   Førre, Øystein ^m   Tuomilehto, Jaakko ^n,o,p   Laiho, Kari ^q   Jiang, Lei ^r   Liu, Yu ^r   Wu, Xin ^r   Bradbury, Linda A ^a   Elewaut, Dirk ^s   Burgos Vargas, Ruben ^t   Stebbings, Simon ^u   Appleton, Louise ^b   Farrah, Claire ^b   Lau, Jonathan ^b   Kenna, Tony J ^a   Haroon, Nigil ^v   Ferreira, Manuel A ^w   Yang, Jian ^a   Mulero, Juan ^x   Fernandez Sueiro, Jose Luis ^y   Gonzalez Gay, Miguel A ^z   Lopez Larrea, Carlos ^aa,ab   Deloukas, Panos ^ac   Donnelly, Peter ^ad   Bowness, Paul ^b   Gafney, Karl ^ae   Gaston, Hill ^af   Gladman, Dafna D ^ag,ah,ai   Rahman, Proton ^aj   Maksymowych, Walter P ^ak   Xu, Huji ^r   Crusius, J Bart A ^al   Van Der Horst Bruinsma, Irene E ^al   Chou, Chung Tei ^am,an   Valle Oñate, Raphael ^ao   Romero Sánchez, Consuelo ^ao   Hansen, Inger Myrnes ^ap   Pimentel Santos, Fernando M ^aq   Inman, Robert D ^v   Videm, Vibeke ^ar,as   Martin, Javier ^at   Breban, Maxime ^h,i   Reveille, John D ^g   Evans, David M ^au   Kim, Tae Hwan ^c   Wordsworth, Bryan Paul ^b   Brown, Matthew A ^a   more..

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Nuffield Orthopaedic Centre ^*  (United Kingdom)

^c Hanyang University Hospital for Rheumatic Diseases   (South Korea)

^d Eulji University   (South Korea)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^g UNIVERSITY OF TEXAS   (United States)

^h INSTITUT COCHIN   (France)

ⁱ LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^j UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^k ROYAL DARWIN HOSPITAL   (Australia)

^l UNIVERSITY OF OSLO   (Norway)

^m OSLO UNIVERSITY HOSPITAL   (Norway)

ⁿ DANUBE UNIVERSITY KREMS   (Austria)

^o NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^p KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^q PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^r SECOND MILITARY MEDICAL UNIVERSITY   (China)

^s GHENT UNIVERSITY HOSPITAL   (Belgium)

^t HOSPITAL GENERAL DE MÉXICO   (Mexico)

^u UNIVERSITY OF OTAGO   (New Zealand)

^v TORONTO WESTERN HOSPITAL   (Canada)

^w ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^x HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^y Instituto de Investigacion Biomedica A Coruna INIBIC   (Spain)

^z Rheumatology Department   (Spain)

^aa Asturias Central University Hospital   (Spain)

^ab Section of Nephrology   (Spain)

^ac WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^ad UNIVERSITY OF OXFORD   (United Kingdom)

^ae NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^af UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ag UNIVERSITY OF TORONTO   (Canada)

^ah UNIVERSITY HEALTH NETWORK   (Canada)

^ai UNIVERSITY HEALTH NETWORK   (Canada)

^aj MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^ak UNIVERSITY OF ALBERTA   (Canada)

^al VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^am TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^an NATIONAL YANG MING UNIVERSITY   (Taiwan)

^ao UNIVERSIDAD DE LA SABANA   (Colombia)

^ap Helgelandssykehuset ^*  (Norway)

^aq NOVA MEDICAL SCHOOL   (Portugal)

^ar NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^as TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^at INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^au MEDICAL RESEARCH COUNCIL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; HLA B27 ANTIGEN; INTERLEUKIN 23; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANKYLOSING SPONDYLITIS; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPING TECHNIQUE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN PROCESSING; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GENOTYPING TECHNIQUES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HLA-B27 ANTIGEN; HUMANS; IMMUNE SYSTEM PROCESSES; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SPONDYLITIS, ANKYLOSING;

EID: 84879691837     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2667     Document Type: Article

References (68)

1. Braun, J., Listing, J. & Sieper, J. Overestimation of the prevalence of ankylosing spondylitis in the Berlin study: comment on the article by Braun et al-Reply. Arthritis Rheum. 52, 4049-4050 (2005).
2. Ng, S.C. et al. Epidemiology of spondyloarthritis in the People's Republic of China: review of the literature and commentary. Semin. Arthritis Rheum. 37, 39-47 (2007).
3. Brown, M.A., Laval, S.H., Brophy, S. & Calin, A. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann. Rheum. Dis. 59, 883-886 (2000).
4. Brown, M.A. et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum. 40, 1823-1828 (1997).
5. Burton, P.R. et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet. 39, 1329-1337 (2007).
6. Evans, D.M. et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat. Genet. 43, 761-767 (2011).
7. Reveille, J.D. et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat. Genet. 42, 123-127 (2010).
8. Lin, Z. et al. A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis. Nat. Genet. 44, 73-77 (2012).
9. Cortes, A. & Brown, M.A. Promise and pitfalls of the Immunochip. Arthritis Res. Ther. 13, 101 (2011).
10. Trynka, G. et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat. Genet. 43, 1193-1201 (2011).
11. Ferreira, M.A. et al. Identification of IL6R and chromosome 11q13.5 as risk loci for asthma. Lancet 378, 1006-1014 (2011).
12. Melzer, D. et al. A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet. 4, e1000072 (2008).
13. Mizuki, N. et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci. Nat. Genet. 42, 703-706 (2010).
14. Remmers, E.F. et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nat. Genet. 42, 698-702 (2010).
15. Ait Badi, M.A. et al. Skeletal manifestations in Behcet's disease. A report of 79 cases. Rev. Med. Interne 29, 277-282 (2008).
16. Harvey, D. et al. A common functional variant of endoplasmic reticulum aminopeptidase 2 (ERAP2) that reduces major histocompatibility complex class I expression is not associated with ankylosing spondylitis. Rheumatology 50, 1720-1721 (2011).
17. Tsui, F.W. et al. Association of an ERAP1-ERAP2 haplotype with familial ankylosing spondylitis. Ann. Rheum. Dis. 69, 733-736 (2010).
18. Evnouchidou, I. et al. A common single nucleotide polymorphism in Endoplasmic Reticulum Aminopeptidase 2 induces a specificity switch that leads to altered antigen processing. J. Immunol. 189, 2383-2392 (2012).
19. Andrés, A.M. et al. Balancing selection maintains a form of ERAP2 that undergoes nonsense-mediated decay and affects antigen presentation. PLoS Genet. 6, e1001157 (2010).
20. Lévy, F. et al. The final N-terminal trimming of a subaminoterminal proline-containing HLA class I-restricted antigenic peptide in the cytosol is mediated by two peptidases. J. Immunol. 169, 4161-4171 (2002).
21. Xia, Z. et al. A 17q12 allele is associated with altered NK cell subsets and function. J. Immunol. 188, 3315-3322 (2012).
22. Trynka, G. et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat. Genet. 45, 124-130 (2013).
23. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
24. Ferreira, M.A. et al. Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control. Am. J. Hum. Genet. 86, 88-92 (2010).
25. Davidson, S.I. et al. Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum. 60, 3263-3268 (2009).
26. Kumar, P., Henikoff, S. & Ng, P.C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073-1081 (2009).
27. Adzhubei, I.A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248-249 (2010).
28. Sato, K. et al. Strong evidence of a combination polymorphism of the tyrosine kinase 2 gene and the signal transducer and activator of transcription 3 gene as a DNA-based biomarker for susceptibility to Crohn's disease in the Japanese population. J. Clin. Immunol. 29, 815-825 (2009).
29. Strange, A. et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat. Genet. 42, 985-990 (2010).
30. Ban, M. et al. Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor. Eur. J. Hum. Genet. 17, 1309-1313 (2009).
31. Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238 (2006).
32. Kenna, T.J. et al. Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis. Arthritis Rheum. 64, 1420-1429 (2012).
33. Appel, H. et al. Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response. Arthritis Res. Ther. 13, R95 (2011).
34. Pearce, E.L. et al. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 302, 1041-1043 (2003).
35. Yagi, R. et al. The transcription factor GATA3 actively represses RUNX3 protein-regulated production of interferon-γ. Immunity 32, 507-517 (2010).
36. Cruz-Guilloty, F. et al. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J. Exp. Med. 206, 51-59 (2009).
37. Intlekofer, A.M. et al. Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 321, 408-411 (2008).
38. Park, J.H. et al. Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells. Nat. Immunol. 11, 257-264 (2010).
39. Rakowski, L.A. et al. Convergence of the ZMIZ1 and NOTCH1 pathways at C-MYC in acute T lymphoblastic leukemias. Cancer Res. 73, 930-941 (2013).
40. Hartgring, S.A., Willis, C.R., Bijlsma, J.W., Lafeber, F.P. & van Roon, J.A. Interleukin-7 aggravated joint inflammation and tissue destruction in collagen-induced arthritis is associated with T-cell and B-cell activation. Arthritis Res. Ther. 14, R137 (2012).
41. Muto, A. et al. Bach2 represses plasma cell gene regulatory network in B cells to promote antibody class switch. EMBO J. 29, 4048-4061 (2010).
42. Song, I.H. et al. Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial. Arthritis Rheum. 62, 1290-1297 (2010).
43. Huang, X., Li, Y., Tanaka, K., Moore, K.G. & Hayashi, J.I. Cloning and characterization of Lnk, a signal transduction protein that links T-cell receptor activation signal to phospholipase Cγ1, Grb2, and phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA 92, 11618-11622 (1995).
44. Evnouchidou, I. et al. Cutting Edge: Coding single nucleotide polymorphisms of endoplasmic reticulum aminopeptidase 1 can affect antigenic peptide generation in vitro by influencing basic enzymatic properties of the enzyme. J. Immunol. 186, 1909-1913 (2011).
45. Saveanu, L. et al. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat. Immunol. 6, 689-697 (2005).
46. Colbert, R.A. et al. HLA-B27 misfolding activates the IL-23/IL-17 axis via the unfolded protein response in transgenic rats: evidence for a novel mechanism of inflammation. Arthritis Rheum. 1283, S515 (2007).
47. Karaderi, T. et al. Evidence of genetic association between TNFRSF1A encoding the p55 tumour necrosis factor receptor, and ankylosing spondylitis in UK Caucasians. Clin. Exp. Rheumatol. 30, 110-113 (2012).
48. Gregory, A.P. et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 488, 508-511 (2012).
49. Hemminki, K., Li, X., Sundquist, K. & Sundquist, J. Familial association of inflammatory bowel diseases with other autoimmune and related diseases. Am. J. Gastroenterol. 105, 139-147 (2010).
50. Thjodleifsson, B., Geirsson, A.J., Bjornsson, S. & Bjarnason, I. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland. Arthritis Rheum. 56, 2633-2639 (2007).
51. Danoy, P. et al. Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease. PLoS Genet. 6, e1001195 (2010).
52. Laukens, D. et al. Evidence for significant overlap between common risk variants for Crohn's disease and ankylosing spondylitis. PLoS ONE 5, e13795 (2010).
53. Franke, A. et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 42, 1118-1125 (2010).
54. Sawcer, S. et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214-219 (2011).
55. Onozawa, Y. et al. Activation of T cell death-associated gene 8 regulates the cytokine production of T cells and macrophages in vitro. Eur. J. Pharmacol. 683, 325-331 (2012).
56. Ryder, C., McColl, K., Zhong, F. & Distelhorst, C.W. Acidosis promotes Bcl-2 family mediated evasion of apoptosis: involvement of acid-sensing G protein-coupled receptor GPR65 signaling to MEK/ERK. J. Biol. Chem. 287, 27863-27875 (2012).
57. Khan, M.A., Kushner, I. & Braun, W.E. Association of HLA-A2 with uveitis in HLA-B27 positive patients with ankylosing spondylitis. J. Rheumatol. 8, 295-298 (1981).
58. Liu, J.B. et al. Association of vitiligo with HLA-A2: a meta-analysis. J. Eur. Acad. Dermatol. Venereol. 21, 205-213 (2007).
59. Noble, J.A. et al. HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. Diabetes 59, 2972-2979 (2010).
60. van der Linden, S., Valkenburg, H.A. & Cats, A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 27, 361-368 (1984).
61. Shah, T.S. et al. optiCall: a robust genotype-calling algorithm for rare, low-frequency and common variants. Bioinformatics 28, 1598-1603 (2012).
62. Fraley, C. & Raftery, A.E. Model-based clustering, discriminant analysis, and density estimation. J. Am. Stat. Assoc. 97, 611-631 (2002).
63. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007).
64. Lippert, C. et al. FaST linear mixed models for genome-wide association studies. Nat. Methods 8, 833-835 (2011).
65. Pruim, R.J. et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26, 2336-2337 (2010).
66. 1000 Genomes Project Consortium.. A map of human genome variation from population-scale sequencing. Nature 467, 1061-1073 (2010).
67. Li, Y., Willer, C.J., Ding, J., Scheet, P. & Abecasis, G.R. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol. 34, 816-834 (2010).
68. Wellcome Trust Case Control Consortium. Genomewide association study of 14,000 cases of seven common diseases and 3000 controls. Nature 447, 661-678 (2007).